Title: Computers, regulations and long time relationships
1Computers, regulations and long time relationships
- Hasse Greiner
- Novo Nordisk A/S
- Computer Related Systems Quality
2Novo NordiskGeneral information
- Headquarters Denmark
- International Production facilities in six
countries, affiliates or offices in 68 countries - Workforce18,756 employees (Dec 2003)
- Approximately 60 of employees are located in
Denmark, 40 in the rest of the world
3Product Range
- Novo Nordisk has the broadest diabetes product
portfolio in the industry. We also have a leading
position in areas such as haemostasis management,
growth disorders and hormone replacement therapy.
4The speaker
- Electronics engineer, 1976
- Plant automation, 1976
- programming
- project manager
- System validation since 1988
- Corporate system QA and validation, 1995
- corporate procedures
- audits
- reviews and approvals
- support and training
- inspection support
5Operational Environment
- The pharma industry is regulated and Novo
Nordisk is part of it
6Regulations
- A regulation (as a legal term) is a rule created
by an administrative agency or body that
interprets the statute(s) setting out the
agency's purpose and powers, or the circumstances
of applying the statute.
7Developments of Regulations
- Food and Drug Act of 1906 was passed.
- Reason Disclosure of unsanitary meat processing
False therapeutic claims for patent medicines
were basically unregulated, as the manufacturer
had only to show that he personally believed that
his remedy worked to avoid prosecution
8Development of Regulations
- The need for regulations has stepped up with each
historical crisis - 1938 Dr. Massengills Elixir Sulfanilamid,
causing 107deaths - 1940 Winthrop Chemical Companys sulfathiazole
tablets contaminated with Phenobarbital causing
over 300 deaths. - 1962 Thalidomide. US narrowly avoided the
tragedy but Europe and Canada was hurt by over
10.000 cases of severe deformities.
9Development of Regulations
- 1973 Drug cGMPs were introduced
- 1976 Device cGMP were added
- Reason Problems with Dalkon Shield intrauterine
devices were reported, and injuries resulted. - 1997 21CFR11..!
Regulations are currently rather comprehensive..
however
10Development of Regulations
- 2002 Pharmaceutical cGMPs for the 21st Century
A Risk-Based Approach. - Reason FDA thought regulations were becoming
too developed and wanted the pharma industry to
be able to take better advantage of advanced
technologies. - Changes to FDAs cGMPs to be expected in 2005.
11Prevalence of computers
- Computers are used extensively across the entire
pharma-product value chain
I am a patient
Discovery
Pre-clinical tests
Clinical tests
Manufacture, sales and distribution
I am monitoring the safety of our marketed
products
Every operation is supported or run by
computers
12Computers add to the complexity!
- Computers are social beings they multiply
- Programs include more and more features
- Computers interconnect
- IT Infrastructures grow
- Computers open up for the world to see.
We must still provide documented assurance that
everythings under control and performs as
specified.
13Functional environment
System specifications
Problem management
Operations instructions
training
System owner
Environments
Platform administrators
Critical parameters
Application experts
System administrator
Configuration item list
User manuals
Users
Suppliers
Technical support
revalidation
IT supporters
Auditors
audit reports
Descriptions of responsibilities
QA/Validation
System definition
AI-calibration
Service Level Agreements
Change requests
Data security
Admission control
Non-conformities
Qualification and validation documentation
logbook
security set-up
User requirements
System manuals
14Responsibilities
- The pharma-firm is responsible for all aspects
concerning their products safety, quality,
purity, strength and identification.
- The pharma-firm cant blame it on someone else
- so it must take appropriate actions to ensure
compliance.
- VALIDATION is the key word
15Key validation elements
- Independent QA/QC involvement
- SOPS and documentation
- Life cycle oriented all phases
- Written and pre-approved plans
- High quality records to prove that plans were
followed - Configuration and Change Management
- User Access Controls
- Did I mention documentation?
Control and compliance!
16Extent of Validation
- The extent of validation necessary will depend on
a number of factors including the use to which
the system is to be put, whether the validation
is to be prospective or retrospective and whether
or not novel elements are incorporated.
Validation should be considered as part of the
complete life cycle of a computer system. This
cycle includes the stages of planning,
specification, programming, testing,
commissioning, documentation, operation,
monitoring and modifying.
EUGood Manufacturing Practice
17Suppliers now speak validatian!
- Facilitated by, eg.
- ISPE/GAMP-guides
- conferences
- customer/supplier interactions
- economic incentives?
- Suppliers are gradually becoming aware of
validation requirements - speak the same language
- if with an accent
18How can suppliers further contribute to achieve
compliance and control?
- Pharma firms are inherently cautious as we might
hurt the public physically or ourselves
financially. - Pharma firms need their suppliers to be familiar
with the pharma domain and pertinent regulations. - we cant inspect and test everything ourselves
- we must apply a risk based approach and ltsighgt
rely on our suppliers to their part properly.
19How can suppliers further contribute?
- We must maintain system life long, good working
relationships with suppliers. - keep an open dialog
- be as honest as possible
- learn and teach
- do on site audits from time to time
- But accept severance if shortcomings persist
20How can suppliers further contribute?
- My personal wish for all computers intended for
use in Novo Nordisk. - Useful
- Robust
- Predictable
- Effective
- Secure
- Maintainable
- Scalable
- Well documented
21Theres a happy QA-person ?
Thank you all and enjoy your lunch